Iovance Biotherapeutics Inc
General ticker "IOVA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6B
Iovance Biotherapeutics Inc follows the US Stock Market performance with the rate: 3.0%.
Estimated limits based on current volatility of 2.4%: low 7.20$, high 7.55$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.23$, 11.96$]
- 2024-12-30 to 2025-12-30 estimated range: [5.23$, 11.71$]
Financial Metrics affecting the IOVA estimates:
- Negative: Non-GAAP EPS, $ of -1.88 <= 0.10
- Negative: Operating profit margin, % of -99.74 <= 1.03
- Negative: Operating cash flow per share per price, % of -18.23 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: -0.96 < Investing cash flow per share, $ of -0.66
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term IOVA quotes
Long-term IOVA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $1.19MM |
| Operating Expenses | $342.70MM | $398.88MM | $461.75MM |
| Operating Income | $-342.70MM | $-398.88MM | $-460.56MM |
| Non-Operating Income | $0.45MM | $2.98MM | $13.04MM |
| R&D Expense | $259.04MM | $294.78MM | $344.08MM |
| Income(Loss) | $-342.25MM | $-395.89MM | $-447.52MM |
| Taxes | $0.00MM | $0.00MM | $-3.48MM |
| Profit(Loss) | $-342.25MM | $-395.89MM | $-444.04MM |
| Stockholders Equity | $621.66MM | $499.64MM | $584.61MM |
| Inventory | $0.00MM | $0.00MM | $10.37MM |
| Assets | $777.33MM | $663.98MM | $780.35MM |
| Operating Cash Flow | $-227.94MM | $-292.76MM | $-361.82MM |
| Capital expenditure | $37.57MM | $20.43MM | $22.29MM |
| Investing Cash Flow | $0.13MM | $256.45MM | $-155.24MM |
| Financing Cash Flow | $239.27MM | $190.15MM | $462.96MM |
| Earnings Per Share* | $-2.14 | $-2.45 | $-1.89 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.